JCR Pharmaceuticals announced that it will present data at the 22nd Annual WORLDSymposium 2026, held February 2-6, 2026, in San Diego, Calif.
An estimated 60% of patients with Alzheimer's disease develop epilepsy or subclinical epileptiform activity over the course of the disease. New-onset seizures in cognitively healthy adults also ...
Look for these powerhouses if you want science-backed results.
A massive NASCAR Rule Book update was posted on Friday and removes every instance of ‘the playoffs’ and ‘playoff points’ to ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...
By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...
ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, showing best-in-class potential for ...
Nonetheless, the authors concluded, “Liver biopsy is considered the gold standard for diagnosing MASH and MASLD. While ...
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...
Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a growing societal burden exacerbated by population aging. Traditional ...
Struggling with blind pimples? Learn how to treat cystic acne fast with dermatologist-approved products and proven at-home treatments.
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results